BRAIN Biotech AG BNN
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- €2.78
- Day Range
- €2.47–2.82
- 52-Week Range
- €2.13–3.89
- Bid/Ask
- €0.00 / €0.00
- Shares Outstanding
- 21.85M
- Market Cap
- €61.61M
- Volume/Avg
- 5,081 / 5,644
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1.34
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
BRAIN Biotech AG is an industrial biotechnology specialist focused on enzyme technology, microbial production strains, and bioprocess design to enable bio-based innovations. The Group conducts research, development, and production for client specifications and its own product portfolio, supporting customers in the food and beverage, chemical, and life sciences industries with solutions that enhance productivity, efficiency, and sustainability. Its operations are organized into two segments: BRAIN Biocatalysts, which develops, produces, and distributes specialty enzymes, microorganisms, and ingredients and generates the majority of revenue, and BRAIN BioIncubator, which focuses on development projects. The company operates in Germany and other countries.
- Sector
- Basic Materials
- Industry
- Specialty Chemicals
- Stock Style Box
- Small Value
- Total Number of Employees
- 268
- Website
- https://www.brain-biotech.com
Valuation
|
Metric
|
BNN
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 1.34 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
BNN
|
|---|---|
Quick Ratio | 0.00 |
Current Ratio | 1.34 |
Interest Coverage | −3.87 |
Quick Ratio
BNN
Profitability
|
Metric
|
BNN
|
|---|---|
Return on Assets (Normalized) | −20.26% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −124.24% |
Return on Assets
BNN
Specialty Chemicals Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Linde PLC
LIN
| LOCK|>^<$J@^ | LOCK|KM | $236B | |||
| Ecolab Inc
ECL
| LOCK|DrV^WnM | LOCK|^@# | $85B | |||
| Sherwin-Williams Co
SHW
| LOCK|>$&<Y@SS | LOCK|<^J | $80B | |||
| Air Products and Chemicals Inc
APD
| LOCK|RM^XDVd | LOCK|<$ | $70B | |||
| PPG Industries Inc
PPG
| LOCK|g!<M^% | LOCK|>&N?& | $26B | |||
| International Flavors & Fragrances Inc
IFF
| LOCK|DjW^vJV | LOCK|vw#$? | $24B | |||
| LyondellBasell Industries NV Class A
LYB
| LOCK|%gd^$!@ | LOCK|n@>^> | $22B | |||
| DuPont de Nemours Inc
DD
| LOCK|PfqMZv# | LOCK|P#X<> | $19B | |||
| Sociedad Quimica Y Minera De Chile SA ADR
SQM
| LOCK|VHd!>< | LOCK|N?Lnm | $17B | |||
| Albemarle Corp
ALB
| LOCK|H@Mrx> | LOCK|cx>> | $11B |
United States